Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Download references

Open Access

The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts

Dušan Milanović*, Friederike Braun, Wolfgang Weber, Anca Ligia Grosu, Martin Behe and Gabriele Niedermann

BMC Cancer 2012, 12:242  doi:10.1186/1471-2407-12-242